Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.48
Delayed Data
As of Jun 15
 +0.03 / +2.07%
Today’s Change
1.28
Today|||52-Week Range
4.52
-14.94%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.45
Today’s open1.45
Day’s range1.45 - 1.48
Volume24,399
Average volume (3 months)109,136
Market cap$17.2M
Data as of 4:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)+44.29%
Earnings growth (this year)+78.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
APRIApricus Biosciences ...-0.02-5.26%
ACSTAcasti Pharma Inc-0.09-11.58%
HTBXHeat Biologics Inc+0.11+5.24%
KTOVKitov Pharma Ltd-0.02-0.71%
Data as of 4:00pm ET, 06/15/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$7.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts